Skip to main content

Table 3 Distribution of risk factors proposed to contribute to prolonged disease course and, or severity in both intervention groups

From: Nebulised hypertonic saline (3 %) among children with mild to moderately severe bronchiolitis - a double blind randomized controlled trial

Variables

3 % HS + L-Epi

0.9 % NS + L-Epi

p-value

(n = 50)

(n = 50)

Family history of asthma, n (%)

4 (8.0)

5 (10.0)

1.00

Parental smoking, n (%)

30 (60.0)

21 (42.0)

0.05

Exposure to biofuels, n (%)

14 (28.0)

8 (16.0)

0.11

Breastfeeding status, n (%)

48 (96.0)

48 (96.0)

0.75

Prematurity, n (%)

3 (6.0)

2 (4.0)

0.50

Atopic history, n (%)

7 (14.0)

3 (6.0)

0.15